methyclothiazide has been researched along with Premenstrual Syndrome in 1 studies
Methyclothiazide: A thiazide diuretic with properties similar to those of HYDROCHLOROTHIAZIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p825)
Premenstrual Syndrome: A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BUSHNELL, LF | 1 |
1 other study available for methyclothiazide and Premenstrual Syndrome
| Article | Year |
|---|---|
METHYCLOTHIAZINE IN THE MANAGEMENT OF PREMENSTRUAL TENSION.
Topics: Disease Management; Drug Therapy; Female; Humans; Methyclothiazide; Premenstrual Syndrome | 1965 |